Is sentinel-node biopsy superior to nodal observation in melanoma?: Commentary

Nature Clinical Practice Oncology

Volumn 4, Issue 5, 2007, Pages 278-279

  Gershenwald, Jeffrey E ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; EARLY INTERVENTION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; MICROMETASTASIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SHORT SURVEY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 34248504647     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0791     Document Type: Short Survey

References (5)

1. Balch C et al. (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7: 87-97
2. Cascinelli N et al. (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. WHO Melanoma Programme. Lancet 351: 793-796
3. Gershenwald J et al. (1999) Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17: 976-983
4. Wrightson WR et al. (2003) Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 10: 676-680
5. Gershenwald JE et al. (2000) Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 7: 226-231